On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
HOME > ACADEMIA
ACADEMIA
- Japan Hypertension Society to Soon Report VART Paper Retraction in Publication
September 26, 2016
- Univ. of Tokyo to Launch Probe into 22 Scientific Papers after Data Manipulation Claims
September 23, 2016
- Japan, Korea NCCs to Collaborate in Personnel Exchanges, Joint Research
September 7, 2016
- JAMS Pres. Takaku, Global Scientists Call for HPV Vaccine Recommendation
August 30, 2016
- Japan Hypertension Society to Retract Diovan Paper on VART Study
August 16, 2016
- Japan Society Draws Up New Guidelines on Depression
August 16, 2016
- 3 Scientific Societies to Set Up HBOC Body to Build BRCA Gene Database
August 4, 2016
- Scientific Panel Fails to Reach Consensus on Withdrawal of Antiresorptive Agents Before Oral Invasive Surgery
July 27, 2016
- New Enuresis Treatment Guidelines Recommend Desmopressin as First-Line Pharmacotherapy: Japanese Society on Enuresis
July 26, 2016
- Regenerative Medicine Society to Introduce Treatment Compensation System in November
July 26, 2016
- Japanese Society of Nephrology Aims to Promote Development through “Surrogate Endpoints”; Hopes to Draft Guidelines in FY2017
July 22, 2016
- 1st Line Statins Likely to Be Recommended for Pediatric Familial Hypercholesterolemia
July 21, 2016
- New Atherosclerosis Guidelines Likely to Add PCSK9 Inhibitors for Primary Prevention of CAD in Familial Hypercholesterolemia
July 20, 2016
- Japan Oncology Society Warns of Privately Imported Opdivo, Yervoy
July 19, 2016
- JSGO Will Revise Guidelines to Recommend Bevacizumab in Treatment of Stage IVB/Relapsed Cervical Cancer
July 14, 2016
- Biosimilar Use Should Be Required Under Publicly Funded Systems: JSGM Pres.
July 13, 2016
- Japan Esophageal Society to Recommend 5-FU + Cisplatin as 1st-Line Therapy for Esophageal Cancer in New Guidelines
July 7, 2016
- MHLW Working Group Drafting Guidelines for Development of Cell Therapies for Cerebral Infarction
July 4, 2016
- Accelerate Investigator-Initiated Trials to Promote Academia-Led Drug Discovery: New NCGM Research Center Chief
July 1, 2016
- 865,238 People Diagnosed with Cancer in 2012: NCC
June 30, 2016
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
As Japan’s budget season draws near, the Ministry of Finance (MOF) has renewed its push for a full-scale “off-year” drug…
Japan will trim the NHI price of Eli Lilly Japan’s Alzheimer’s treatment Kisunla (donanemab) by 3.93% under the cost-effectiveness assessment…
Japan is set to add 16 new drugs to its NHI reimbursement price list on November 13, including a subcutaneous…
Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…